Loading...
Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
Lung cancer has become one of the leading causes of death in both men and women in the United States, with approximately 230,000 new cases and 160,000 deaths each year. Approximately 80% of lung cancer patients are diagnosed with non-small-cell lung cancer (NSCLC), a subset of epithelial lung cancer...
Na minha lista:
| Udgivet i: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217515/ https://ncbi.nlm.nih.gov/pubmed/28210149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S69114 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|